TABLE 5.
Colorectal cancers identified during APC trial
Patient | Study treatment | Time from randomization to detection of CRC (months) | Post-treatment adenoma available for staining? | Biomarker status at baseline (Pre-treatment) | |
---|---|---|---|---|---|
Cox-2 | 15-PGDH | ||||
…688 | placebo | 6 | Yes | high | absent |
…168 | placebo | 36 | Yes | low | absent |
…192 | placebo | 36 | Yes | low | absent |
…691 | celecoxib | 12 | No | N/D | N/D |
…623 | celecoxib | 36 | Yes | low | absent |
…036 | celecoxib | 36 | Yes | low | absent |
…293 | celecoxib | 36 | Yes | low | absent |